We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 9.00 | 9.00 | 9.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -6.34 | 52.55M |
From May 2019 to May 2024
TIDMETX
RNS Number : 3365H
e-Therapeutics plc
12 March 2018
e-Therapeutics plc
("e-Therapeutics" or the "Company")
Notification of Full Year Results Date
Oxford, UK - 12 March 2018 - e-Therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its full year results for the year ended 31 January 2018 on Tuesday, 27 March 2018.
-Ends-
For more information, please contact:
e-Therapeutics plc Tel: +44 (0)1993 Raymond Barlow, CEO 883 125 Steve Medlicott, Finance www.etherapeutics.co.uk Director Numis Securities Limited Tel: +44 (0) 207 Michael Meade / Freddie Barnfield 260 1000 (Corporate Finance) www.numis.com James Black (Corporate Broking) Instinctif Partners Tel: +44 (0) 207 Melanie Toyne Sewell / Alex 457 2020 Shaw / Deborah Bell Email: e-therapeutics@instinctif.com
About e-Therapeutics plc
e-Therapeutics is an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.
Its novel methodology and Discovery Engine allow the Company to discover new and better drugs in a more efficient and effective way.
For more information about the Company, please visit www.etherapeutics.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBXGDXCSBBGIB
(END) Dow Jones Newswires
March 12, 2018 03:00 ET (07:00 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
